Immunotoxin Therapy in Treating Patients With Advanced Cancer

NCT00006981 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Cervical Cancer
Fallopian Tube Cancer
Head and Neck Cancer
Lung Cancer
Malignant Mesothelioma
Ovarian Cancer
Pancreatic Cancer
Primary Peritoneal Cavity Cancer

Interventions

BIOLOGICAL: SS1(dsFv)-PE38 immunotoxin

Sponsor

National Cancer Institute (NCI)